AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2023
May 31, 2023
30339_dirs_2023-05-31_7159f922-6e0f-42cf-9bed-5787313603f1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2023-05-30
Reporting Person: Winters Chad (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-30 | Common Stock | M | 872.00 | $143.43 | Acquired | 2320.711 | Direct |
| 2023-05-30 | Common Stock | M | 872.00 | $339.51 | Disposed | 1448.711 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-05-30 | Stock Options (Right to buy) | $143.43 | M | 872.00 | Disposed | 2029-10-29 | Common Stock (872.00) | Direct |
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27